Die folgenden Begriffe wurden einbezogen:
Tumorprogression, Progression, "tumor progression", 腫瘍プログレッション, 進行
-
1999,
Yaguchi H, Yoshida M, Ejima Y, Miyakoshi J
Mutat Res Genet Toxicol Environ Mutagen 440 (2): 189-194
-
1998,
Bakaliuk TG, Zoria LV, Pogorila MA
Patol Fiziol Eksp Ter (4): 22-25
-
1998,
Mevissen M, Häußler M, Lerchl A, Loscher W
J Toxicol Environ Health A 53 (5): 401-418
-
Bioelectromagnetics 18 (3): 1-19
-
Bioelectromagnetics 19 (4): 210-221
-
Int J Neurosci 94 (1-2): 41-54
-
1997,
Matsumura H, Kobayashi Y, Mann R, Sugamata A, Watanabe K, Harunari N, Yoshizawa N, Kamada T, Engrav LH, Heimbach DM
J Burn Care Rehabil 18 (4): 299-305
-
Radiat Prot Dosimetry 72 (3-4): 279-290
-
1997,
McCann J, Kavet R, Rafferty CN
Environ Health Perspect 105: 81-103
-
1997,
Xin YL, Xue F, Zhao F
Chin Med J 110 (5): 379-383
-
Cancer Causes Control 8 (3): 323-332
-
Int J Neurosci 90 (3-4): 177-185
-
Int J Neurosci 91 (3-4): 189-197
-
Int J Neurosci 89 (1-2): 39-51
-
1997,
Antonopoulos A, Eisenbrandt H, Obe G
Mutat Res Genet Toxicol Environ Mutagen 395 (2-3): 209-214
-
Bioelectromagnetics 18 (2): 156-165
-
1997,
Shen YH, Shao BJ, Chiang H, Fu YD, Yu M
Bioelectromagnetics 18 (5): 360-364
-
1997,
Inaloz SS, Dasdag S, Ceviz A, Bilici A
Clin Exp Obstet Gynecol 24 (4): 215-219
-
1996,
Haberal M, Ucar N, Bayraktar U, Oner Z, Bilgin N
Burns 22 (2): 158-161
-
Bioelectromagnetics 17 (6): 475-482
-
1996,
Rubin J, McLeod KJ, Titus L, Nanes MS, Catherwood BD, Rubin CT
J Orthop Res 14 (1): 7-15
-
Int J Neurosci 88 (1-2): 75-82
-
1996,
Sasser LB, Morris JE, Miller DL, Rafferty CN, Ebi KL, Anderson LE
Carcinogenesis 17 (12): 2681-2687
-
1995,
Ghosh D, Gupta A, Kohli A
Aust N Z J Med 25 (3): 263-264
-
1995,
Shimizu H, Suzuki Y, Okonogi H
Nihon Eiseigaku Zasshi 50 (5): 919-931